Evidence map›Paper›PMID 34156286›Full record

ArticlemSystems2021

The DNA Sensor IFIX Drives Proteome Alterations To Mobilize Nuclear and Cytoplasmic Antiviral Responses, with Its Acetylation Acting as a Localization Toggle.

Timothy R Howard, Marni S Crow, Todd M Greco, Krystal K Lum, Tuo Li, Ileana M Cristea

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. When DNA-damage responses meet innate and adaptive immunity.Cellular and molecular life sciences : CMLS · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Karyopherin-mediated nucleocytoplasmic transport.Nature reviews. Molecular cell biology · 2022
    Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Timothy R Howard *Department of Molecular Biology, Princeton Universitygrid.16750.35, Princeton, New Jersey, USA.
Marni S Crow *Department of Molecular Biology, Princeton Universitygrid.16750.35, Princeton, New Jersey, USA.
Todd M Greco *Department of Molecular Biology, Princeton Universitygrid.16750.35, Princeton, New Jersey, USA.
Krystal K LumDepartment of Molecular Biology, Princeton Universitygrid.16750.35, Princeton, New Jersey, USA.
Tuo LiDepartment of Molecular Biology, Princeton Universitygrid.16750.35, Princeton, New Jersey, USA.
Ileana M CristeaDepartment of Molecular Biology, Princeton Universitygrid.16750.35, Princeton, New Jersey, USA.
Princeton University · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007388 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 1985 to 2022
$27.4M
Mechanisms mediating immune response upon sensing of nuclear viral DNAR01GM114141 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 2015 to 2023
$2.6M
Emerging roles for interferon inducible protein IFIX in innate immune responseF31AI114240 · NIAID · PRINCETON UNIVERSITY · PI CROW, MARNI S · 2015 to 2017
$121k
Bridging virology with proteomics to define cell immune signaling upon infectionF31GM120936 · NIGMS · PRINCETON UNIVERSITY · PI LUM, KRYSTAL KAR-YAN · 2017 to 2018
$89k
Edward Mallinckrodt, Jr. Foundation (EMF)HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI114240HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM114141HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM120936HHS | NIH | National Institute of General Medical Sciences (NIGMS) T32GM007388NIAID NIH HHS F31 AI114240NIGMS NIH HHS F31 GM120936NIGMS NIH HHS R01 GM114141NIGMS NIH HHS T32 GM007388Princeton Catalysis Initiative
6 · The paper itself

Abstract

DNA sensors are critical components of innate immunity that enable cells to recognize infection by pathogens with DNA genomes. The interferon-inducible protein X (IFIX), a member of the PYHIN protein family, is a DNA sensor capable of promoting immune signaling after binding to double-stranded DNA (dsDNA) within either the nucleus or cytoplasm. Here, we investigate the impact of IFIX on the cellular proteome upon introduction of foreign DNA to the nucleus or the cytoplasm as well as regulatory hubs that control IFIX subcellular localization. Using quantitative mass spectrometry, we define the effect of CRISPR-mediated IFIX knockout on nuclear and cytoplasmic proteomes in fibroblasts. Proteomes are probed in response to either nuclear viral DNA, during herpes simplex virus 1 (HSV-1) infection, or cytoplasmic viral DNA, following transfection with dsDNA derived from vaccinia virus (VACV 70-mer). We show that IFIX broadly impacts nuclear and cytoplasmic proteomes, inducing alterations in the abundances of immune signaling, DNA damage response, and vesicle-mediated transport proteins. To characterize IFIX properties that regulate its localization during DNA sensing, we perform deletion and mutagenesis assays. We find that IFIX contains a multipartite nuclear localization signal (NLS) and highlight the main contributing motif for its nuclear localization. Using immunoaffinity purification, we identify IFIX acetylation and phosphorylation sites. Mutations to acetyl or charge mimics demonstrate that K138 acetylation, positioned within the NLS, affects nuclear localization. Altogether, our study establishes a mechanism regulating IFIX subcellular localization and contextualizes this localization with the involvement of IFIX in host cell responses to pathogenic DNA.

Indexed as

DNA sensingHSV-1IFIXinnate immunitylysine acetylationmass spectrometryposttranslational modificationproteomics

Identifiers

PMID34156286
PMCPMC8269231
OpenAlexW3176799080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.